Drug Reference

Proparacaine

Proparacaine hydrochloride

Brand names:Alcaine, Ophthaine, Ophthetic

Anesthetic - LocalStandard EMS

An ester-type topical local anesthetic used for ophthalmic procedures. Proparacaine enables emergency ocular examination, foreign body removal, fluorescein staining setup, and tonometry. Rapid onset (under 30 seconds) and minimal stinging make it the field-preferred topical ocular anesthetic. Must never be dispensed for patient self-administration - chronic use causes severe corneal injury.

Mission Capable - Minor Impact

Administration may produce minor effects (mild drowsiness, GI upset, or similar) but does not typically remove the recipient from duty. Monitor for individual response.

Pharmacology and Actions

Proparacaine is an ester-type topical local anesthetic. It blocks voltage-gated sodium channels on corneal and conjunctival sensory nerve endings, preventing nerve conduction and producing surface anesthesia. Rapid onset (within 13 seconds) reflects its lipid solubility and the thin corneal epithelial barrier. Rapid hydrolysis by tissue and plasma esterases limits the duration to 10 to 20 minutes.

Indications

  • Topical ocular anesthesia for foreign body removal
  • Topical ocular anesthesia for tonometry and gonioscopy
  • Suture removal from cornea or conjunctiva
  • Facilitates ocular exam in patients with severe pain or blepharospasm
  • Adjunct for fluorescein staining and Wood lamp examination

Absolute Contraindications

  • Known hypersensitivity to proparacaine or ester-type local anesthetics
  • Penetrating eye injury (delays diagnosis and masks symptoms)

Precautions and Side Effects

Common: transient stinging or burning on instillation lasting seconds. Rare with single use: redness, lacrimation, allergic conjunctivitis. With repeated use: corneal epithelial toxicity, delayed healing, neurotrophic keratitis, ring infiltrates, ulceration, permanent visual loss - this is why proparacaine should never be dispensed for repeated self-use. No clinically significant systemic interactions when used at recommended ophthalmic doses. Sulfonamides may have reduced antimicrobial efficacy when combined with ester anesthetics (PABA metabolite competition) - rarely clinically relevant. Pregnancy Category C. Minimal systemic absorption; considered compatible with lactation. Pediatric and elderly use at standard dosing.

Adult Dosing

IV / IO
None Onset: None
IM
None Onset: None
IN
None Onset: None
PO
None Onset: None

Pediatric Dosing

Same as adult dosing: 1 to 2 drops of 0.5 percent solution. Used in pediatric ocular exams when needed.

Pharmacokinetics

Peak Effect: 20 to 60 seconds.

Duration: 10 to 20 minutes.

Storage and Handling

Refrigerate (2 to 8 degrees C) to maintain stability. Discard if solution becomes discolored (brown or yellow). Some formulations are room temperature stable for limited duration; check labeling. Protect from light. Single-use vials preferred for field use.

Reconstitution:

Available as 0.5 percent ophthalmic solution. No reconstitution required.

TCCC and TECC Role

Proparacaine is not in the TCCC core formulary. It appears in tactical EMS supplemental formularies for ocular foreign body removal and pain control during eye examinations after blast injury, chemical exposure, or operational eye trauma. Mission impact is minor at single-dose level: the operator can return to function once anesthesia wears off, but cannot reliably protect the eye during the 10 to 20 minute anesthetic window.

Field Context

Proparacaine is the workhorse topical ocular anesthetic in emergency settings. The operational scenario is straightforward: operator with a foreign body sensation in the eye, severe blepharospasm preventing a useful exam, or pain disproportionate to obvious injury. One drop of proparacaine allows immediate examination, fluorescein staining, and often simple foreign body removal at the lid margin or peripheral cornea. Always pair with fluorescein staining and Wood lamp or cobalt-blue light evaluation - the anesthesia masks pain that would otherwise warn of corneal injury.

Common Mistake

Dispensing proparacaine to a patient for repeated use. This is the most well-documented misuse pattern in emergency medicine and causes severe corneal injury (proparacaine keratopathy, ring infiltrates, ulceration, permanent visual loss). One dose in the clinic or aid station, document, send the patient for definitive ophthalmologic evaluation, but never let the bottle leave with the patient. The other mistake is using proparacaine instead of ophthalmologic referral for penetrating eye injury - if there is any concern for globe penetration, do not instill anything; protect the eye with a shield and transport.

Clinical Reference Notice

This drug profile is provided as educational reference material for trained medical providers. It is not medical advice, not a substitute for formal training, and not a substitute for current published guidelines or medical direction.

Drug administration is governed by your scope of practice, agency standing orders, medical director protocols, and applicable state and federal regulations. Controlled substances are subject to additional handling, accountability, and documentation requirements per DEA and state law. Always verify dosing, indications, contraindications, and route of administration against current published guidelines and your local protocols before administration.

If this content is being viewed during a medical emergency, call 911 immediately and follow the direction of your local emergency dispatch and medical control. Do not use this reference as a substitute for emergency medical services.

Drug information evolves. Last reviewed dates and source citations are provided for each entry. Confirm currency against the cited source before clinical use.

Penn Tactical Solutions publishes this reference for educational purposes. PTS does not provide medical direction and does not assume responsibility for clinical decisions made in the field. Clinical responsibility rests with the administering provider, their medical director, and their agency.

Educational reference for trained medical providers. Not medical advice. Not a substitute for formal training, current published guidelines, or medical direction. Drug administration is governed by your scope of practice, agency standing orders, medical director protocols, and applicable state and federal regulations. Controlled substances require additional storage, accountability, and documentation per DEA and state law.

In a medical emergency, call 911. This reference is not a substitute for emergency medical services.

Verify dosing, indications, and contraindications against current published guidelines and your local protocols before administration. Confirm content currency against the source citation. Penn Tactical Solutions does not provide medical direction. Clinical responsibility rests with the administering provider, their medical director, and their agency.

Proparacaine

Proparacaine hydrochloride
Anesthetic - Local
Mission Capable - Minor Impact
Adult Dosing
IV/IO None (None)
IM None (None)
IN None (None)
PO None (None)
Pediatric
Same as adult dosing: 1 to 2 drops of 0.5 percent solution. Used in pediatric ocular exams when needed.
Contraindications
Known hypersensitivity to proparacaine or ester-type local anesthetics| Penetrating eye injury (delays diagnosis and masks symptoms)
Common Mistake
Dispensing proparacaine to a patient for repeated use. This is the most well-documented misuse pattern in emergency medicine and causes severe corneal injury (proparacaine keratopathy, ring infiltrates, ulceration, permanent visual loss). One dose in the clinic or aid station, document, send the patient for definitive ophthalmologic evaluation, but never let the bottle leave with the patient. The other mistake is using proparacaine instead of ophthalmologic referral for penetrating eye injury - if there is any concern for globe penetration, do not instill anything; protect the eye with a shield and transport.